Astera Labs climbs as RBC lifts target to $250 on Amazon Trainium catalyst

ALABALAB

Astera Labs shares rose after RBC Capital lifted its price target to $250 from $225, reiterating an Outperform rating. The call pointed to incremental revenue opportunity from Scorpio switch products as Amazon ramps Trainium deployments, with Scorpio‑X volume shipments expected in Q3 2026.

1. What’s moving the stock

Astera Labs (ALAB) traded higher as investors reacted to a fresh bullish analyst reset focused on the company’s exposure to next-generation AI infrastructure connectivity. RBC Capital raised its price target on ALAB to $250 from $225 while reiterating an Outperform rating, framing the upside around expanding switch content per AI rack and improving visibility into hyperscaler deployments. (streetinsider.com)

2. The core catalyst: Amazon Trainium and Scorpio switch upside

The bullish thesis centers on Astera’s Scorpio switch family and the expected ramp of next-gen Scorpio‑X. The RBC note highlighted an expanding revenue runway for Scorpio switches in 2026 and argued that Scorpio‑X adds incremental opportunity per XPU as deployments scale, with volume shipments expected to begin in Q3 2026. This “content-per-system” dynamic is key because Astera’s connectivity attach rate can rise as AI clusters move toward higher-bandwidth, rack-scale designs. (fool.com)

3. Why the market is paying attention now

Astera has already been executing against a fast-growth narrative, reporting Q4 2025 revenue of $270.6 million (+17% sequential) and 2025 full-year revenue growth of 115% year-over-year—results that reinforced investor confidence in demand for AI connectivity silicon and systems. With the stock sensitive to hyperscaler capex signals and product-cycle timing, incremental positives on Trainium-linked switch ramps can quickly translate into outsized moves on otherwise quiet news days. (asteralabs.gcs-web.com)

4. What to watch next

Traders are likely to focus on (1) any follow-on analyst revisions, (2) management commentary and confirmations around Scorpio‑X timing into the Q3 2026 window, and (3) Amazon-related mechanics that can influence sentiment. Astera previously disclosed a long-dated warrant agreement allowing Amazon’s investment arm to acquire up to 3,262,299 shares exercisable through February 5, 2033, with vesting tied to commercial performance—an arrangement that underscores strategic demand but can also be viewed as a potential future supply/overhang variable. (tipranks.com)